DENTSPLY SIRONA’s (XRAY) In-Line Rating Reiterated at Evercore ISI

Evercore ISI restated their in-line rating on shares of DENTSPLY SIRONA (NASDAQ:XRAYFree Report) in a research note released on Tuesday morning, MarketBeat reports. The brokerage currently has a $20.00 target price on the medical instruments supplier’s stock.

Several other research analysts also recently commented on the company. StockNews.com downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Tuesday, November 19th. Leerink Partnrs cut DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 7th. Leerink Partners cut DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Thursday, November 7th. UBS Group lowered their price objective on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research report on Tuesday, December 3rd. Finally, Barrington Research reduced their target price on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a research report on Friday, November 8th. Nine research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $27.27.

Get Our Latest Research Report on XRAY

DENTSPLY SIRONA Price Performance

Shares of XRAY stock opened at $18.85 on Tuesday. The stock’s fifty day simple moving average is $19.36 and its 200 day simple moving average is $23.18. DENTSPLY SIRONA has a one year low of $17.21 and a one year high of $37.60. The firm has a market cap of $3.75 billion, a price-to-earnings ratio of -9.11, a P/E/G ratio of 1.93 and a beta of 0.96. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last posted its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.02. The business had revenue of $951.00 million for the quarter, compared to analyst estimates of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The firm’s quarterly revenue was up .4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.49 EPS. On average, analysts expect that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 10th. Investors of record on Friday, December 27th will be issued a $0.16 dividend. The ex-dividend date of this dividend is Friday, December 27th. This represents a $0.64 dividend on an annualized basis and a yield of 3.40%. DENTSPLY SIRONA’s dividend payout ratio is presently -30.92%.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several institutional investors have recently modified their holdings of XRAY. UMB Bank n.a. raised its holdings in DENTSPLY SIRONA by 430.3% in the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock worth $25,000 after purchasing an additional 753 shares during the period. Capital Performance Advisors LLP bought a new position in shares of DENTSPLY SIRONA during the 3rd quarter valued at about $27,000. Kennebec Savings Bank acquired a new position in shares of DENTSPLY SIRONA in the 3rd quarter valued at approximately $35,000. Van ECK Associates Corp bought a new stake in DENTSPLY SIRONA during the 3rd quarter worth approximately $42,000. Finally, Allworth Financial LP raised its holdings in DENTSPLY SIRONA by 40.2% during the 3rd quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier’s stock worth $59,000 after buying an additional 625 shares during the period. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Company Profile

(Get Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Recommended Stories

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.